349 results on '"Term (time)"'
Search Results
2. PCN25 Systematic Literature Review of Treatment Patterns, Long-Term Efficacy, and Safety of Dasatinib Therapy for Patients with Chronic Myeloid Leukemia
3. PCV2 Real-World Outcomes of Antithrombotic Therapies in Patients with Coronary Artery Disease That Require Long-Term Oral Anticoagulation
4. PCN11 The potential long-term comparative effectiveness of larotrectinib vs. lenvatinib or sorafenib for treatment of NTRK fusion-positive metastatic thyroid cancer
5. PSY26 Healthcare Costs, Resource Utilization, and Adverse Events Associated with Long-term Oral Corticosteroid Use in Patients with Systemic Lupus Erythematosus in the United States
6. PMS5 EARLY CARE DECISIONS AND THE RISK OF LONG-TERM OPIOID USE IN PATIENTS WITH LOW BACK PAIN
7. PMH11 LONG-TERM MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER IN THE UNITED STATES: A COST-UTILITY ANALYSIS
8. PCV27 COST-EFFECTIVENESS OF INSERTABLE CARDIAC MONITORS VERSUS STANDARD OF CARE OR SHORT-TO-LONG-TERM ECG MONITORING TO IDENTIFY ATRIAL FIBRILLATION AFTER CRYPTOGENIC STROKE
9. PCV22 LONG-TERM BENEFITS OF EXPANDED ACCESS TO VALVE REPLACEMENT FOR AORTIC STENOSIS PATIENTS
10. PDB6 LONG-TERM ASSOCIATION OF OBSERVED VERSUS PREDICTED MICRO- AND MACROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES MELLITUS: EXTERNAL VALIDATION OF THE CORNERSTONE DIABETES SIMULATION MODEL (CDSM)
11. PGI58 A STUDY OF LONG TERM HOSPITALIZATION COSTS IN PATIENTS WITH ULCERATIVE COLITIS USING GERMAN CLAIMS DATA
12. PDB51 PREVENTION AS A PUBLIC HEALTH MEASURE: LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF A POPULATION-BASED IODINE DEFICIENCY DISEASES PREVENTION PROGRAM
13. PUK14 ACUTE Renal Failure during COVID-19 and Its LONG-TERM IMPACT on Health System
14. PDB28 MODEL-Based LONG-TERM Cost-Effectiveness of Once-Weekly Semaglutide Compared with Other GLP-1 Receptor Agonists in Type 2 Diabetes: A Systematic Literature Review
15. PRS9 LONG-TERM IMPACT of PRIOR Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilisation (HCRU) and Related Costs: An Observational Study (SHERLOCK)
16. PCN348 Long-Term Healthcare Resource Utilization and Costs Associated with Patients Treated with Nivolumab for Advanced Non-Small Cell Lung Cancer
17. PDB32 A LONG-TERM Cost-Effectiveness Analysis of Treatments for Type 2 Diabetes in Portugal: Once-Weekly Semaglutide 1 MG Versus Once-Daily Empagliflozin 25 MG
18. PND27 Modelling LONG-TERM Health Benefits of Siponimod in ACTIVE Secondary Progressive Multiple Sclerosis in Portugal
19. PDG18 LONG-TERM Cost-Effectiveness of the Sofosbuvir-Based Directing-Acting Antivirals in Treating Patients with Chronic Hepatitis C (CHC) in China: From a Healthcare Payer’S Perspective
20. PRO11 Estimating the LONG-TERM Effects of Therapy for Patients with Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) Using Individual Participant DATA
21. PMS32 LONG–TERM PAIN Management Pathways of Patients with Osteoarthritis of the HIP/Knee before Joint Replacement — a Retrospective Cohort Study Based on German Health Claims DATA
22. PND15 LONG-TERM COST-EFFECTIVENESS OF LASMIDITAN, UBROGEPANT AND RIMEGEPANT FOR TREATMENT OF ACUTE MIGRAINE
23. PDG12 THE LONG-TERM COST-EFFECTIVENESS OF VILDAGLIPTIN+ METFORMIN THERAPY RELATIVE TO COMPARATOR SULFONYLUREA+ METFORMIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
24. PCN4 ACCURACY OF LIFE YEAR GAIN PREDICTIONS FOR NIVOLUMAB MONOTHERAPY IN THE LONG TERM: AN ANALYSIS ACROSS FOUR INDICATIONS
25. PBI33 HOW NOVEL IS ICER METHODS GUIDANCE ON HIGH-IMPACT, SINGLE, AND SHORT-TERM THERAPIES?
26. PIH35 LONG-TERM PRESCRIPTION OPIOID USE AMONG OLDER ADULTS IN THE UNITED STATES
27. PCN121 LONG-TERM COST-EFFECTIVENESS MODELING COMPARING MATURITY OF DATA CUTS: A COMPARISON BETWEEN COST-EFFECTIVENESS OF NIVOLUMAB VS EVEROLIMUS IN SECOND LINE RENAL CELL CARCINOMA USING 2- OR 3-YEAR FOLLOW UP CHECKMATE-025 DATA
28. PRS23 THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN TO THE HEALTHCARE SYSTEM AND FAMILIES OF PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS IN INDONESIA
29. PRO128 AN EVIDENCE-BASED APPROACH TO PREDICT LONG-TERM PATIENT OUTCOMES IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME
30. PIN48 THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA
31. PRO50 THE ECONOMIC BURDEN OF SHORT-TERM ADVERSE EVENTS ASSOCIATED WITH THE CHOP CHEMOTHERAPY REGIMEN IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS IN EUROPEAN COUNTRIES: A COMPREHENSIVE LITERATURE REVIEW
32. PMH16 LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION
33. PCV18 THE LONG-TERM EFFECTS OF MAINTAINING RAASI TREATMENT IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW
34. PCN20 ACCURATE PREDICTIONS OF LIFE YEAR GAINS FOR IMMUNO-ONCOLOGY THERAPIES IN THE LONG TERM? AN ANALYSIS BASED ON PUBLISHED CHECKMATE 057 NIVOLUMAB DATA
35. PDG106 EFFECTS OF STATIN THERAPY ON LONG-TERM HEALTH CARE OUTCOMES AND MEDICAL COST-BASED ON CHINA REGIONAL HEALTH INSURANCE CLAIM DATABASE
36. PUK2 A SYSTEMATIC REVIEW ASSESSING THE LONG-TERM EFFECTS OF MAINTAINING RAASI TREATMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE
37. PMU30 A SYSTEMATIC REVIEW OF PREVIOUSLY PUSBLISHED OR APPRAISED HEALTH ECONOMIC MODELS ESTIMATING THE SHORT- AND LONG-TERM CONSEQUENCES OF STEROID-SPARING AGENTS
38. PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
39. PMH54 - PATTERNS OF LONG-TERM CUSTODIAL CARE IN PARKINSON DISEASE PSYCHOSIS
40. PDB64 - SHORT-TERM COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC IN JAPANESE PATIENTS WITH TYPE 2 DIABETES
41. PDB74 - IDEGLIRA VERSUS IGLARLIXI FOR PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN: A LONG-TERM COST-EFFECTIVENESS ANALYSIS IN THE CZECH REPUBLIC
42. Long-Term Effects of Antimicrobial Stewardship Program in A Chinese Tertiary General Hospital: An Interrupted Time-Series Analysis
43. Management of Asymptomatic Term & Late Preterm Newborns Exposed to Maternal Intrapartum Fever: A Societal Cost Benefit Analysis of the Proposed 'Triple I' Algorithm
44. The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia: A Microsimulation Study
45. The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia
46. PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
47. PMH34 LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS
48. PCN306 REAL-WORLD STUDY OF HEALTHCARE UTILIZATION AND LONG-TERM PRODUCTIVITY LOSS IN CHRONIC GRAFT VERSUS HOST DISEASE IN SWEDEN
49. PSU22 LONG TERM COST EFFECTIVENESS OF BARIATRIC SURGERY COMPARED TO DIET IN ITALY: PRELIMINARY RESULTS
50. PMU57 A REMEDY FOR DESPAIR? SHORT-TERM CHANGES IN ECONOMIC CONDITIONS AND OPIOID PRESCRIBING IN WASHINTON STATE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.